The global microbial identification market size is anticipated to reach USD 7.95 billion by 2030 and is anticipated to expand at a CAGR of 11.8% during the forecast period, according to a new report by Grand View Research, Inc. The rising prevalence of infectious diseases and the need for rapid and accurate identification of microbial pathogens have created a strong demand for advanced identification technologies. This is particularly marked in healthcare settings, where on time diagnosis and treatment of infections are critical for patient outcomes. According to Australian Institute of Health and Welfare, July 2022 statistics, in 2020-21, there were around 3,24,000 hospitalizations for infectious diseases, 94% of which were non-notifiable. In addition, the raising awareness of food safety and the need to control foodborne pathogens have led to the adoption of microbial identification techniques in the food industry, further driving the market growth.
Moreover, advancements in technology such as automation and real time analysis play a pivotal role in the expansion of this market. Innovations such as next-generation sequencing, mass spectrometry, and automated microbial identification systems have enhanced the speed and accuracy of microbial identification, making them more accessible and reliable. For instance, in April 2023, Bruker introduced new MBT Mycobacteria IVD Kit offers best-in-class diagnostic solutions and user-friendly for infection diagnostics laboratories and routine clinical microbiology. These technological advancements have attracted the attention of both clinical laboratories and research institutions, driving market growth.
The regulatory environment has also had an impact on the growth of the microbial identification industry. To maintain product safety and compliance, numerous industries, including pharmaceuticals, healthcare, and food, have implemented stringent rules and quality control standards, necessitating the employment of accurate identification procedures. To meet regulatory standards, has boosted the introduction of microbiological identification solutions.
However, the cost of microbiological identification tools and technology can be a considerable obstacle. High initial capital investment and continuous operational costs can dissuade healthcare facilities and laboratories from adopting this advanced equipment, particularly in resource-constrained situations. Thus, the cost aspect may limit the market's reach, particularly in poor countries.
Request a free sample copy or view report summary: Microbial Identification Market Report
The consumables segment dominated the product & services segment with a revenue share of 36.51% in 2023, owing to the rising demand for animal-free cell-based therapies
The software & services segment is expected to grow at the fastest CAGR over the forecast period due to the advancements in technology which focuses on development of specialized software that can better support the unique needs of different genetic pool of microorganisms for better microbial identification
The PCR segment dominated the technology segment with a revenue share in 2023, owing to the technological advancement in the field of microbial identification
The genotypic segment dominated the method segment with a revenue share in 2023 and expected to maintain the same over the forecast period
The clinical diagnostics segment dominated the application segment with a revenue share in 2023, due to the growing number of research & diagnostic activities for various drug and vaccine development
Based on end use, the hospitals & diagnostic laboratories segment dominated the market in 2023. On the other hand, pharmaceutical & biotechnology companies is expected to witness the fastest growth over the forecast period
The North America region dominated the market owing to factors such as the presence of key market players rising adaptation of advance technology in identification and rising research and development in various fields. Moreover, the growing prevalence of infectious diseases is further anticipated to boost the market for microbial identification in the region over the forecast period
Asia Pacific is expected to register the fastest growth over the forecast period due to several companies expanding their presence in Asia Pacific countries like Japan and India
Grand View Research has segmented global microbial identification market on the basis of product & services, technology, method, application, end-use, and region:
Microbial Identification Product & Services Outlook (Revenue, USD Million, 2018 - 2030)
Instruments
Mass Spectrometers
PCR Systems
Microarrays
Others
Consumables
Reagents & Kits
Plates & Media
Software & Services
Identification Services
Culture Collection Services
Assay Validation Services
Microbial Identification Technology Outlook (Revenue, USD Million, 2018 - 2030)
Mass Spectrometry
PCR
Microarrays
Next Generation Sequencing
Others
Microbial Identification Method Outlook (Revenue, USD Million, 2018 - 2030)
Phenotypic Methods
Genotypic Methods
Proteotypic Methods
Microbial Identification Application Outlook (Revenue, USD Million, 2018 - 2030)
Clinical Diagnostics
Pharmaceuticals
Food & Beverage Testing
Environmental Application
Others
Microbial Identification End-use Outlook (Revenue, USD Million, 2018 - 2030)
Pharmaceutical and Biotechnology Companies
Hospitals and Diagnostic Laboratories
Food Testing Laboratories
Others
Microbial Identification Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
South Korea
Australia
Thailand
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Microbial Identification Market
bioMérieux SA
Becton, Dickinson and Company
ThermoFisher Scientific Inc.
Bruker Corporation
Danaher Corporation
Qiagen N.V.
Charles River Laboratories
Wickham Micro Limited
VWR International LLC. (Avantor Inc.)
Shimadzu Corporation
Merck KGaA
Eurofins Scientific SE
Biolog Inc
"The quality of research they have done for us has been excellent..."